BNP PARIBAS FINANCIAL MARKETS - SYNTA PHARMACEUTICALS CORP ownership

SYNTA PHARMACEUTICALS CORP's ticker is SNTA and the CUSIP is 87162T206. A total of 81 filers reported holding SYNTA PHARMACEUTICALS CORP in Q1 2014. The put-call ratio across all filers is 2.65 and the average weighting 1.1%.

Quarter-by-quarter ownership
BNP PARIBAS FINANCIAL MARKETS ownership history of SYNTA PHARMACEUTICALS CORP
ValueSharesWeighting
Q4 2015$5,926,000
-81.9%
16,932
-9.9%
0.00%
Q3 2015$32,691,000
+93.9%
18,788
+148.5%
0.00%
Q2 2015$16,859,000
+455.3%
7,560
+383.1%
0.00%
Q1 2015$3,036,000
-75.7%
1,565
-62.2%
0.00%
Q3 2014$12,470,000
+778.8%
4,143
+1093.9%
0.00%
Q2 2014$1,419,000
-48.5%
347
-34.0%
0.00%
Q4 2013$2,756,000
-96.0%
526
-95.2%
0.00%
Q3 2013$69,259,000
-8.1%
10,976
-27.4%
0.00%
Q2 2013$75,404,00015,1110.00%
Other shareholders
SYNTA PHARMACEUTICALS CORP shareholders Q1 2014
NameSharesValueWeighting ↓
CAXTON CORP 37,069,140$64,500,00087.00%
ARMISTICE CAPITAL, LLC 2,000,000$3,480,0001.19%
IRONWOOD INVESTMENT MANAGEMENT LLC 432,259$752,0000.28%
Geller Advisors LLC 187,323$326,0000.21%
CAXTON CORP 57,000$99,0000.13%
Verity Asset Management, Inc. 64,476$112,0000.11%
TFS CAPITAL LLC 367,364$639,0000.06%
Cutler Capital Management, LLC 72,500$126,0000.06%
LUCAS CAPITAL MANAGEMENT 21,100$37,0000.02%
Nine Chapters Capital Management LLC 129,700$226,0000.02%
View complete list of SYNTA PHARMACEUTICALS CORP shareholders